Utah Medical Products, Inc.
UTMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -1.4% | 2.5% | 6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 51.6% | 50.8% | 57% | 58.1% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 41.4% | 46% | 43.1% | 43.5% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 26.8% | 30.6% | 31.3% | 31.7% |
| EPS Diluted | 0.82 | 0.94 | 0.92 | 0.86 |
| % Growth | -12.8% | 2.2% | 7% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | -$0 | -$0 | -$0 |
| Free Cash Flow | – | $0 | $0 | $0 |